StockNews.com started coverage on shares of OpGen (NASDAQ:OPGN – Free Report) in a research report released on Monday. The brokerage issued a sell rating on the medical research company’s stock.
OpGen Stock Performance
Shares of OPGN opened at $0.60 on Monday. OpGen has a twelve month low of $0.17 and a twelve month high of $3.84. The firm’s 50 day moving average price is $0.56 and its two-hundred day moving average price is $0.51. The firm has a market cap of $7.55 million, a P/E ratio of -0.09 and a beta of -0.71.
About OpGen
Further Reading
- Five stocks we like better than OpGen
- Stock Sentiment Analysis: How it Works
- It’s Time to Buy Into the Super Micro Computer Stock Implosion
- Why is the Ex-Dividend Date Significant to Investors?
- Merger or Not, Albertson’s Companies is a Good Buy
- How to invest in blue chip stocks
- 3 Cheap Stocks That Shouldn’t Be So
Receive News & Ratings for OpGen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OpGen and related companies with MarketBeat.com's FREE daily email newsletter.